Cassava Sciences, Inc. SAVA
Set alert
1.32 USD 0.00 0.00%
As of May 22, 12:35 PM ET
1.27 Day range 1.35
2.23 52-week range 42.20
- YTD
- -33.33%
- 1 year
- -25.42%
- Open
- 1.30
- Prev close
- 1.32
- Mkt cap
- 115.95M
- Vol
- 134.26K
- Avg vol
- 5.19M
- EPS
- -1.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.27
- High
- 1.35
- Forward P/E
- -1.36
- Beta
- -0.58
- Short ratio
- 1.95
- Inst. own
- 29.93%
- Dividend
- 0.00
- Ex-div date
- Dec 12, 2012
- 50-d avg
- 17.99
- 200-d avg
- 21.09
- 1y target
- 0.00
2Y chart
Events in this range
- May 10, 2024Earnings: -1.41; estimate -0.51; surprise -176.47%
- Jul 19, 2024Rating: HC Wainwright & Co. · — → Neutral
- Aug 8, 2024Rating: Rodman & Renshaw · Buy → Buy
- Aug 8, 2024Earnings: -1.28; estimate -0.44; surprise -190.91%
- Aug 13, 2024Rating: HC Wainwright & Co. · — → Neutral
- Oct 8, 2024Rating: HC Wainwright & Co. · Neutral → Buy
- Nov 7, 2024Earnings: -0.58; estimate -1.37; surprise 57.66%
- Nov 8, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 26, 2024Downgrade: HC Wainwright & Co. · Buy → Neutral
Signals (85)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 11, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 11, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 10, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 8 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Dec 19, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Nov 28, 2025 | 11 months ago |
| SMA: Bullish | Nov 26, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 22, 2025 | 1 year ago |
| RSI: Overbought | Oct 14, 2025 | 1 year ago |
| RSI: Overbought | Oct 8, 2025 | 1 year ago |
| RSI: Overbought | Oct 3, 2025 | 1 year ago |
| RSI: Overbought | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 4, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 3, 2025 | 1 year ago |
| SMA: Bearish | Aug 29, 2025 | 1 year ago |
| SMA: Bullish | Aug 28, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 28, 2025 | 1 year ago |
| SMA: Bearish | Aug 20, 2025 | 1 year ago |
| SMA: Bullish | Aug 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 31, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 24, 2025 | 1 year ago |
| SMA: Bullish | Jul 22, 2025 | 1 year ago |
| RSI: Overbought | Jul 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| SMA: Bearish | Jun 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 9, 2025 | 1 year ago |
| RSI: Overbought | May 20, 2025 | 1 year ago |
| RSI: Overbought | May 16, 2025 | 1 year ago |
| SMA: Bullish | May 14, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| RSI: Oversold | Mar 26, 2025 | 1 year ago |
| SMA: Bearish | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 25, 2025 | 1 year ago |
| SMA: Bullish | Mar 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 28, 2025 | 1 year ago |
| SMA: Bullish | Feb 27, 2025 | 1 year ago |
| SMA: Bearish | Feb 21, 2025 | 1 year ago |
| SMA: Bullish | Feb 19, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 7, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 28, 2025 | 1 year ago |
| MACD: Buy Signal | Dec 30, 2024 | 1 year ago |
| MACD: Sell Signal | Dec 2, 2024 | 1 year ago |
| SMA: Bearish | Nov 29, 2024 | 1 year ago |
| SMA: Bullish | Nov 27, 2024 | 1 year ago |
| SMA: Bearish | Nov 26, 2024 | 1 year ago |
| SMA: Bullish | Nov 25, 2024 | 1 year ago |
| SMA: Bearish | Nov 22, 2024 | 1 year ago |
| SMA: Bullish | Nov 21, 2024 | 1 year ago |
| SMA: Bearish | Nov 20, 2024 | 1 year ago |
| SMA: Bullish | Nov 18, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 15, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 13, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 11, 2024 | 1 year ago |
| MACD: Sell Signal | Oct 25, 2024 | 2 years ago |
| SMA: Bearish | Oct 23, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 16, 2024 | 2 years ago |
| SMA: Bullish | Oct 15, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 27, 2024 | 2 years ago |
| RSI: Overbought | Jul 31, 2024 | 2 years ago |
| SMA: Bullish | Jul 29, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 16, 2024 | 2 years ago |
| RSI: Oversold | Jun 28, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 25, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 24, 2024 | 2 years ago |
| SMA: Bearish | Jun 4, 2024 | 2 years ago |
| SMA: Bullish | May 30, 2024 | 2 years ago |
| SMA: Bearish | May 29, 2024 | 2 years ago |
| MACD: Sell Signal | May 23, 2024 | 2 years ago |
| MACD: Buy Signal | May 15, 2024 | 2 years ago |
| RSI: Overbought | Apr 8, 2024 | 2 years ago |
Key statistics
- Market cap
- 115.95M
- Enterprise value
- -35.92M
- Trailing P/E
- 0.00
- Forward P/E
- -1.36
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.69
- EPS (TTM)
- -1.38
- Beta
- -0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -82.64M
- Total cash
- 148.98M
- Total debt
- 0
- Return on equity
- -10.98%
- Shares outstanding
- 48.11M
- Short % of float
- 38.06%
- 50-day average
- 17.99
- 200-day average
- 21.09
Analyst view
Consensus: none
Price target (mean) 0.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.68.
Financials — quick view
SAVA Revenue — quarterly 0
SAVA Net income — quarterly -10.81M
SAVA EPS — quarterly -0.22
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 7, 2024 | Sep 1, 2024 | -1.37 | -0.58 | +0.79 | +57.66% |
| Aug 8, 2024 | Jun 1, 2024 | -0.44 | -1.28 | -0.84 | -190.91% |
| May 10, 2024 | Mar 1, 2024 | -0.51 | -1.41 | -0.90 | -176.47% |
| Feb 28, 2024 | Dec 1, 2023 | -0.40 | -0.50 | -0.10 | -25.00% |
| Nov 7, 2023 | Sep 1, 2023 | -0.90 | -0.61 | +0.29 | +32.22% |
| Aug 3, 2023 | Jun 1, 2023 | -0.58 | -0.63 | -0.05 | -8.62% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | HC Wainwright & Co. | down | Buy | Neutral |
| Nov 8, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 8, 2024 | HC Wainwright & Co. | up | Neutral | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | reit | — | Neutral |
| Aug 8, 2024 | Rodman & Renshaw | reit | Buy | Buy |
| Jul 19, 2024 | HC Wainwright & Co. | reit | — | Neutral |
About Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was incorporated in 1998 and is based in Austin, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cassavasciences.com
News
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- HALPER SADEH LLC ENCOURAGES CASSAVA SCIENCES, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
- Cassava Announces Agreement to Settle Securities Class Action Litigation
- 12 Health Care Stocks Moving In Friday's Intraday Session
- FDA Puts Cassava's Simufilam Epilepsy Trial On Full Clinical Hold
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- 12 Health Care Stocks Moving In Monday's After-Market Session
- Comparing Cassava Sciences (NASDAQ:SAVA) and Carisma Therapeutics (NASDAQ:CARM)
- Halper Sadeh LLC Encourages Cassava Sciences, Inc. Shareholders to Contact the Firm to Discuss Their Rights
Your note
Sign in to keep a note on SAVA — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARBIER REMI | Chief Executive Officer | Conversion of Exercise of derivative security | May 23, 2023 | 0 |
| BARRY RICHARD J | Director | Conversion of Exercise of derivative security | Apr 22, 2024 | 0 |
| GUSSIN ROBERT Z | Director | Conversion of Exercise of derivative security | Apr 30, 2023 | 10,617 |
| KUPIEC JAMES WILLIAM | Officer | Sale | Nov 28, 2024 | 0 |
| O DONNELL MICHAEL J | Director | Conversion of Exercise of derivative security | Mar 6, 2023 | 6,873 |
| ROBERTSON SANFORD R | Director | Stock Gift | May 15, 2024 | 1,135,850 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 6.78% | 3,263,474 | 7.86M | Sep 29, 2024 |
| Vanguard Group Inc | 5.24% | 2,522,798 | 6.08M | Sep 29, 2024 |
| State Street Corporation | 2.42% | 1,162,749 | 2.80M | Sep 29, 2024 |
| Geode Capital Management, LLC | 2.10% | 1,008,593 | 2.43M | Sep 29, 2024 |
| Gallacher Capital Management LLC | 1.21% | 580,042 | 1.40M | Sep 29, 2024 |
| Morgan Stanley | 1.08% | 519,544 | 1.25M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.65% | 1,275,948 | 3.08M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.17% | 1,045,518 | 2.52M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.41% | 678,626 | 1.64M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.86% | 415,510 | 1.00M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.75% | 362,957 | 874.73K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.52% | 251,560 | 606.26K | Oct 30, 2024 |